Indietro

Selezionare la regione

Azienda

Richiedi un consulto sulle cellule staminali

Per saperne di più

I nostri
trapianti

Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:

Immagine
Elenco degli utilizzi delle cellule staminali approvati dai laboratori del gruppo FamiCord:
Nr. Fonte Tipo di fonte Diagnosi Settore medico Anno di applicazione Terapia Paese Età del destinatario
3101 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 20
3102 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 74
3103 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 55
3104 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 56
3105 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 48
3106 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 13
3107 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 65
3108 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 48
3109 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 67
3110 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 52
3111 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 50
3112 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 61
3113 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 35
3114 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 61
3115 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 47
3116 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 34
3117 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 62
3118 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 60
3119 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 62
3120 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 64
3121 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 29
3122 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 63
3123 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 1
3124 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 39
3125 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 43
3126 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 63
3127 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Poland 21
3128 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Germany 58
3129 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Germany 45
3130 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Germany 63
3131 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Germany 54
3132 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Germany 48
3133 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Germany 61
3134 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Germany 27
3135 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Germany 61
3136 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2022 Standard Therapy Germany 66
3137 Apheresis Allogeneic Acute Myeloid Leukemia – Relapse Hematology 2022 Standard Therapy Germany 47
3138 Apheresis Allogeneic Acute Myeloid Leukemia; Myelodysplastic Syndrome Hematology 2022 Standard Therapy Germany 55
3139 Apheresis Allogeneic Acute Promyelocytic Leukemia Hematology 2022 Standard Therapy Poland 49
3140 Apheresis Allogeneic Acute Promyelocytic Leukemia Hematology 2022 Standard Therapy Poland 40
3141 Apheresis Allogeneic Alk-Positive Anaplastic T-Cell Lymphoma Hematology 2022 Standard Therapy Poland 15
3142 Apheresis Autologous Anaplastic Large Cell Lymphoma Hematology 2022 Standard Therapy Germany 22
3143 Apheresis Allogeneic Aplastic Anemia Hematology 2022 Standard Therapy Poland 22
3144 Apheresis Allogeneic Aplastic Anemia Hematology 2022 Standard Therapy Poland 16
3145 Apheresis Allogeneic Aplastic Anemia Hematology 2022 Standard Therapy Poland 17
3146 Apheresis Allogeneic Aplastic Anemia Hematology 2022 Standard Therapy Germany 67
3147 Apheresis Allogeneic Atypical Chronic Myeloid Leukemia  Hematology 2022 Standard Therapy Poland 62
3148 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2022 Standard Therapy Poland 46
3149 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2022 Standard Therapy Poland 18
3150 Apheresis Allogeneic B-Cell Acute Lymphoblastic Leukemia Hematology 2022 Standard Therapy Germany 54
3151 Apheresis Allogeneic Beta Thalassemia Major Hematology 2022 Standard Therapy Poland 11
3152 Apheresis Allogeneic C-All Rez (Acute Lymphoblastic Leukemia) Hematology 2022 Standard Therapy Poland 66
3153 Apheresis Allogeneic C-All Rez (Acute Lymphoblastic Leukemia) Hematology 2022 Standard Therapy Poland 5
3154 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2022 Standard Therapy Poland 3
3155 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2022 Standard Therapy Poland 3
3156 Apheresis Allogeneic Chronic Granulomatous Disease Hematology 2022 Standard Therapy Poland 5
3157 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2022 Standard Therapy Poland 63
3158 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2022 Standard Therapy Poland 59
3159 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2022 Standard Therapy Germany 58
3160 Apheresis Allogeneic Chronic Lymphocytic Leukemia Richter Transformation 7/22 Hematology 2022 Standard Therapy Poland 44
3161 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2022 Standard Therapy Poland 64
3162 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2022 Standard Therapy Poland 67
3163 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2022 Standard Therapy Poland 63
3164 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2022 Standard Therapy Poland 59
3165 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2022 Standard Therapy Poland 64
3166 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2022 Standard Therapy Poland 60
3167 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 70
3168 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 54
3169 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 63
3170 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 54
3171 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 71
3172 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 67
3173 Apheresis Allogeneic Chronic Myelomonocytic Leukemia, Type 0 (Cmml-0) Hematology 2022 Standard Therapy Poland 64
3174 Apheresis Allogeneic Chronic Neutrophilic Leukemia Hematology 2022 Standard Therapy Poland 66
3175 Apheresis Allogeneic Chronic Neutrophilic Leukemia Hematology 2022 Standard Therapy Poland 72
3176 Apheresis Allogeneic Combined Immunodeficiency Syndrome With Hyper-Igm Hematology 2022 Standard Therapy Poland 6
3177 Apheresis Allogeneic Congenital Dyserythropoietic Anemia Hematology 2022 Standard Therapy Poland 2
3178 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 68
3179 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 65
3180 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 69
3181 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 50
3182 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 56
3183 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 65
3184 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2022 Standard Therapy Germany 47
3185 Apheresis Autologous Diffuse Large B-Cell Lymphoma – Relapse Hematology 2022 Standard Therapy Germany 66
3186 Apheresis Autologous Diffuse Large B-Cell Lymphoma With Cerebral Acute Lymphoblastic Leukemia Hematology 2022 Standard Therapy Germany 66
3187 Apheresis Autologous Germ Cell Tumor Hematology 2022 Standard Therapy Germany 39
3188 Apheresis Autologous Germ Cell Tumor Hematology 2022 Standard Therapy Germany 33
3189 Apheresis Allogeneic Hemophagocytic Lymphohistiocytosis (Hlh) Hematology 2022 Standard Therapy Poland 12
3190 Apheresis Allogeneic Hemophagocytic Lymphohistiocytosis (Hlh) Hematology 2022 Standard Therapy Poland 21
3191 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 26
3192 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 31
3193 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 53
3194 Apheresis Allogeneic Hodgkin Lymphoma Hematology 2022 Standard Therapy Poland 25
3195 Apheresis Autologous Hodgkin Lymphoma Hematology 2022 Standard Therapy Germany 67
3196 Apheresis Autologous Hodgkin Lymphoma-Relapse Hematology 2022 Standard Therapy Germany 69
3197 Apheresis Autologous Hodgkin Lymphoma-Relapse Hematology 2022 Standard Therapy Germany 48
3198 Apheresis Allogeneic Hypoplastic Myelodysplastic Syndrome Hematology 2022 Standard Therapy Poland 26
3199 Apheresis Allogeneic Immunodeficiency Hematology 2022 Standard Therapy Poland 3
3200 Apheresis Allogeneic Juvenile Myelomonocytic Leukemia Hematology 2022 Standard Therapy Poland 5